Company Summary: LENSAR, Inc.

Overview:
LENSAR, Inc. is a medical device company specializing in ophthalmology, specifically designing and manufacturing laser systems used in cataract surgery.

Key Details:

• Industry: Ophthalmic medical devices, with a focus on laser technology for eye surgery.
• Headquarters: Orlando, Florida (2800 Discovery Drive).
• Stock Symbol: LNSR (traded on Nasdaq).

Business Operations and Financials:

• The company is classified as a smaller reporting company and emerging growth company.
• As of April 28, 2025, it has 11,792,156 shares of common stock outstanding.
• Market value of common stock held by non-affiliates was approximately $37.5 million as of June 30, 2024.

Employees and Customers:

• The document does not specify the number of employees.
• The number of customers is not explicitly mentioned.

Financial Performance (2024):

• The fiscal year ended December 31, 2024.
• The company filed an amendment (Form 10-K/A) in April 2025, but the financial summary details such as revenue and net income are not included within the provided excerpt.

Business Focus and Market:

• The core product involves laser systems used in cataract procedures, aiming to improve precision and outcomes in ophthalmic surgeries.
• The company engages with eyes surgeons and clinics for implementing its laser technologies in cataract surgery procedures.

Note:
The provided document primarily discusses corporate governance, board composition, executive compensation, stock ownership, and related transactions, but does not specify detailed operational metrics such as revenue, earnings, or customer count.